Biotech

Anatara Lifesciences (ASX:ANR) "The Health Kick" podcast with Tim Boreham

🕔10/18/2019 9:52:35 AM

Anatara Lifesciences CEO Steve Lydeamore sat down with Tim Boreham this week for Stockhead's new podcast series, "The Health Kick".

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Financial Report

🕔10/17/2019 10:27:27 AM

Forecast expenditure for the December 2019 quarter is anticipated to increase as the Company advances the development of its Gastrointestinal Reprogramming (GaRP) dietary supplement. A refund from the Australian Taxation Office under the Federal Government's Research and Development (R&D) Tax Incentive scheme is anticipated to be received in December 2019.

Read Full Article

Regeneus Ltd (ASX:RGS) Receives A$1.5 million in R&D Tax Incentives

🕔10/15/2019 11:08:59 AM

Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, has received $1.5 million in R&D Tax Incentives from the Australian Tax Office for FY19.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Reports Statistically Significant Animal Studies

🕔10/14/2019 10:13:52 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to report statistically significant efficacy data from its in vivo mouse studies and further positive in vitro proof of concept data for its Gastrointestinal ReProgramming (GaRP) product.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Annual Report to Shareholders

🕔10/11/2019 10:08:13 AM

Anatara Lifesciences Ltd's (ASX:ANR) lead human health product, GaRP, is being developed to specifically target two human gastrointestinal (GI) disorders, Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS), where there is a significant unmet medical need.

Read Full Article

Regeneus Ltd (ASX:RGS) Financial Report - Year Ended 30 June 2019

🕔9/26/2019 9:32:37 AM

Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, releases its financial results for the financial year ended 30 June 2019 (FY2019).

Read Full Article

Zoono (ASX:ZNO) Signs China Distribution Agreement

🕔9/25/2019 4:12:01 PM

Global technology company Zoono Group Limited (ASX:ZNO) is pleased to announce that it has signed a new sales and distribution agreement in China. The agreement is with Guangzhou Sanchengyun Trade Co., Ltd for the sale of Zoono branded products online in China.

Read Full Article